ANTIHYPERTENSIVE DRUGS: AN ADVANCED COMPREHENSIVE REVIEW OF MECHANISMS, THERAPIES, AND CLINICAL INNOVATIONS

Hypertension is a leading global cause of morbidity and mortality.[4–6], contributing to cardiovascular, renal, and cerebrovascular disease. Antihypertensive pharmacotherapy continues to evolve, with new agents, combination strategies, and device-basedinterventions.[18–23] Precision medicine, pharmacogenomics.[26–28] and digital health technologies.[24–25] are reshaping individualized care. Overview of Major Antihypertensive Drug Classes (Section supported by Goodman & Gilman.[1], Katzung[2], Rang & Dale.[3]

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-16
DOI
https://doi.org/10.5281/zenodo.18255404
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ANTIHYPERTENSIVE DRUGS: AN ADVANCED COMPREHENSIVE REVIEW OF MECHANISMS, THERAPIES, AND CLINICAL INNOVATIONS

Snehal Genbhau Tengle*1, Dr. Amita B. Dongar2, Ms. Ashlesha Gaikwad3
Zenodo (CERN European Organization for Nuclear Research)
Blood Pressure and Hypertension Studies
article

ANTIHYPERTENSIVE DRUGS: AN ADVANCED COMPREHENSIVE REVIEW OF MECHANISMS, THERAPIES, AND CLINICAL INNOVATIONS

Snehal Genbhau Tengle*1, Dr. Amita B. Dongar2, Ms. Ashlesha Gaikwad3
article en

Abstract

Hypertension is a leading global cause of morbidity and mortality.[4–6], contributing to cardiovascular, renal, and cerebrovascular disease. Antihypertensive pharmacotherapy continues to evolve, with new agents, combination strategies, and device-basedinterventions.[18–23] Precision medicine, pharmacogenomics.[26–28] and digital health technologies.[24–25] are reshaping individualized care. Overview of Major Antihypertensive Drug Classes (Section supported by Goodman & Gilman.[1], Katzung[2], Rang & Dale.[3]

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 88%
Blood Pressure and Hypertension Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ANTIHYPERTENSIVE DRUGS: AN ADVANCED COMPREHENSIVE REVIEW OF MECHANISMS, THERAPIES, AND CLINICAL INNOVATIONS — Snehal Genbhau Tengle*1, Dr. Amita B. Dongar2, Ms. Ashlesha Gaikwad3 · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS